Bridgebio Pharma Inc (BBIO) valuation history
$68.56
Latest weekly close · Market cap $13.4B
Share BBIO EV/EBITDA history
As of
BBIO's EV/EBITDA is unavailable because recent financial data is missing.
No EV/EBITDA chart for BBIO right now
BBIO has no current EV/EBITDA reading to compare with its history.
See BBIO's P/S historyEV/EBITDA
n/anot ranked
No EV/EBITDA rank: recent financial data is missing.
Growth, last 12 months vs the year before
- Revenue
- +202%accelerating
- EPS
- n/a
Price vs revenue and EPS, indexed to 100
Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends. EPS was not positive in this window, so it is left out.
PriceRevenue, last 12 months100 = first reading
EV/EBITDA at each year-end
The last weekly reading of each year, and its percentile against the five years before it.
| Year-end | EV/EBITDA | 5-year percentile |
|---|---|---|
| n/a | Too little history | |
| n/a | Too little history | |
| n/a | Too little history | |
| n/a | Too little history |
Loading peers and related research…
About this history
- What is BBIO's current EV/EBITDA?
- BBIO's EV/EBITDA is unavailable because recent financial data is missing.
- What is BBIO's five-year median EV/EBITDA?
- There are not enough weekly readings yet for a five-year median EV/EBITDA.
- Does a low historical rank mean a stock is a buy?
- No. The rank compares BBIO only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.